(Axios) – A review of rules governing Colorado’s psychedelic therapy program will include potentially expanding the substances available for treatment.

Why it matters: The change would make Colorado the first state to use ibogaine — a psychoactive found in the roots of the African shrub iboga — for regulated medical treatment. (Read More)